Product logins

Find logins to all Clarivate products below.


Dr. Srikanth Rajagopal

Managing Partner and Vice President, Commercial Consulting Services

Doc is an experienced management consultant, client partner and practice leader, with close to 20 years of experience selling, leading & delivering a range of product and portfolio strategy, transaction advisory, evidence generation, pricing and market access, commercial strategy and transformation, and business innovation engagements for biopharmaceutical industry clients and their investors across the US, Europe, Asia-Pacific and Japan.​

He believes in a structured, collaborative, expertise-based approach to problem-solving and solution development. Doc partners with colleagues across Clarivate to harness our deep expertise in global healthcare systems, policy, drug development and approval, therapy areas and indications, business development and licensing, pricing and reimbursement systems and processes, customer engagement models and data and advanced analytics to deliver exceptional, impactful outcomes for our clients.​

He previously led Clarivate Europe, Asia-Pacific and Japan Commercial Consulting business, and has held positions of increasing responsibility at global consulting firms such as Guidehouse, IQVIA and Strategic Decisions Group (SDG).

By way of academic qualifications, Doc holds an MBA from the Indian Institute of Management, Ahmedabad and an MBBS (MD equivalent) from the University of Mumbai.


arrow_forward
Get in touch with Srikanth

Latest news

News September 19, 2025
Clarivate Announces the India Research Excellence – Citation Awards 2025

The 10th Edition to Honor Researchers and Institutions for Pioneering Contributions to Research London, U.K. September 19, 2025. Clarivate Plc (NYSE:CLVT), a leading global provider of transformative intelligence, today announced…

News September 18, 2025
BioWorld by Clarivate Celebrates 35 Years of Trusted Biopharma and Medtech Journalism

Award-winning independent news and analysis continue to guide life sciences leaders through rapid scientific and market change London, U.K. — September 18, 2025 — BioWorld, published by Clarivate Plc (NYSE:CLVT),…

News September 18, 2025
Clarivate Releases 2024 Sustainability Report

Annual Report Highlights Achievements in Advancing the UN SDGs London, U.K. September 18, 2025. Clarivate Plc (NYSE: CLVT), a leading global provider of transformative intelligence, today released its 2024 sustainability…

Related resources

Managing uncertainty for medicine in Washington Managing uncertainty for medicine in Washington
Blog May 15, 2025
Managing uncertainty for medicine in Washington
Clinical research Early drug development research Market Access Pharma Portfolio strategy Research Research and development Research commercialization Research evaluation and management
Navigating uncertainty: What’s keeping healthcare execs up at night in this new era Navigating uncertainty: What’s keeping healthcare execs up at night in this new era
Blog April 2, 2025
Navigating uncertainty: What’s keeping healthcare execs up at night in this new era
Market Access Pharma Portfolio strategy Regulatory Research commercialization
Five Medtech Trends to Watch in 2025 Five Medtech Trends to Watch in 2025
Blog February 11, 2025
Five Medtech Trends to Watch in 2025
Medical technology Medtech Medtech Resource Center
The trends to watch in 2025 The trends to watch in 2025
Blog January 8, 2025
The trends to watch in 2025